Use of serum markers in prediction of survival in the trapeze factorial trial evaluating docetaxel with zoledronic acid, strontium-89, or both in castrate-refractory prostate cancer (CRPC) metastatic to bone

Vivek Wadhwa, Kaisheng Wen, Sarah Pirrie, Ann Pope, Nicholas James

Research output: Contribution to journal › Abstract › peer-review

Fingerprint

Dive into the research topics of 'Use of serum markers in prediction of survival in the trapeze factorial trial evaluating docetaxel with zoledronic acid, strontium-89, or both in castrate-refractory prostate cancer (CRPC) metastatic to bone'. Together they form a unique fingerprint.

Medicine & Life Sciences